Related Experiment Videos
Rheological changes in hypertensive patients treated with ramipril
1Section of Cardiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
Clinical Hemorheology and Microcirculation
|January 1, 1997
Summary
Ramipril effectively lowered blood pressure in patients with diastolic hypertension. However, this treatment did not significantly alter blood viscosity, plasma viscosity, serum viscosity, or fibrinogen levels.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Diastolic hypertension is a significant cardiovascular risk factor.
- Understanding the impact of antihypertensive medications on hemorheology is crucial.
Purpose of the Study:
- To investigate the effects of ramipril monotherapy on blood viscosity in patients with mild to moderate diastolic hypertension.
- To assess changes in plasma viscosity, serum viscosity, and fibrinogen levels following ramipril treatment.
Main Methods:
- A cohort of 13 patients with diastolic hypertension received ramipril monotherapy for three months.
- Blood pressure was monitored, and viscosity measurements were performed using a microviscometer.
- Fibrinogen levels were determined using the Clauss method.
Main Results:
- Ramipril significantly reduced both systolic and diastolic blood pressure.
- No statistically significant changes were observed in blood viscosity, plasma viscosity, serum viscosity, or fibrinogen levels.
- The observed blood pressure reduction occurred without adverse hemorheological alterations.
Conclusions:
- Ramipril monotherapy is effective in lowering blood pressure in patients with mild to moderate diastolic hypertension.
- The antihypertensive effects of ramipril were not associated with significant changes in key hemorheological parameters.
- Further research may explore the long-term hemorheological effects of ramipril and its impact on cardiovascular outcomes.